guluronic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aghazadeh, Z; Gholamrezaie, HR; Mahdavi Gorabi, A; Mirshafiey, A; Naderiyan, Z; Nezami Asl, A; Noori Sanami, M; Panahi, Y; Rafia, S; Razavi, A; Robat-Jazi, B; Sadoughi, A; Sanaee Delir, D; Taeb, M | 1 |
1 trial(s) available for guluronic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients.
Topics: Aftercare; COVID-19; Humans; Patient Discharge; SARS-CoV-2 | 2023 |